Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 16 | 22 | 22 | 19 | 18 |
| Accounts receivable | -39 | -167 | -17 | -33 | 536 |
| Other Working Capital | -379 | -139 | -119 | 93 | -153 |
| Other Operating Activity | -3,101 | -2,143 | -1,381 | -543 | -161 |
| Operating Cash Flow | $-3,504 | $-2,425 | $-1,494 | $-463 | $240 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -25 | -24 | -24 | -22 |
| Common Stock Issued | 0 | 0 | 48,629 | 0 | 0 |
| Other Financing Activity | 9 | 250 | 3,436 | 0 | 0 |
| Financing Cash Flow | $-17 | $225 | $52,041 | $-24 | $-22 |
| Exchange Rate Effect | -772 | -17 | 1,630 | 17 | 40 |
| Beginning Cash Position | 55,680 | 57,897 | 5,720 | 6,190 | 5,932 |
| End Cash Position | 51,388 | 55,680 | 57,897 | 5,720 | 6,190 |
| Net Cash Flow | $-3,521 | $-2,200 | $50,547 | $-487 | $218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,504 | -2,425 | -1,494 | -463 | 240 |
| Free Cash Flow | -3,504 | -2,425 | -1,494 | -463 | 240 |